Vaxart, Inc. - Common Stock (VXRT) Financials

VXRT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 91.8 million 34.0 million
2023-09-30 105.6 million 34.1 million
2023-06-30 122.7 million 37.6 million
2023-03-31 129.9 million 40.1 million

VXRT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -13.4 million 3.7 million
2023-09-30 -15.3 million 3.8 million
2023-06-30 -17.9 million 3.9 million
2023-03-31 -25.7 million 2.6 million

VXRT Net Income

No data available :(

VXRT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 20.1 million
2023-09-30 52.2 million - 20.5 million
2023-06-30 67.9 million - 21.0 million
2023-03-31 71.8 million - 21.5 million

VXRT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 153.4 million
2023-09-30 152.0 million
2023-06-30 139.6 million
2023-03-31 135.2 million

VXRT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 14.7 million 5.4 million -
2023-09-30 282000 15.0 million 4.9 million -
2023-06-30 454000 18.8 million 5.6 million -
2023-03-31 1.2 million 19.6 million 6.6 million -

VXRT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 6.6 million -
2023-09-30 446000 15.0 million
2023-06-30 1.4 million -
2023-03-31 675000 -

VXRT

Price: $0.71

52 week price:
0.53
1.59

Earnings Per Share: -0.57 USD

P/E Ratio: -1.87

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.0 million

Ebitda: -2.9 million

Market Capitalization: 154.5 million

Links: